首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis
【2h】

Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis

机译:天然产物HTP筛查活化的巨噬细胞和小胶质细胞中的抗菌药物(大肠杆菌0157:H7)和抗炎剂(大肠杆菌O111:B4的LPS);专注于败血症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAcute systemic inflammatory response syndrome arising from infection can lead to multiple organ failure and death, with greater susceptibility occurring in immunocompromised individuals. Moreover, sub-acute chronic inflammation is a contributor to the pathology of diverse degenerative diseases (Parkinson’s disease, Alzheimer’s disease and arthritis). Given the known limitations in Western medicine to treat a broad range of inflammatory related illness as well as the emergence of antibiotic resistance, there is a renewed interest in complementary and alternative medicines (CAMs) to achieve these means.
机译:背景由感染引起的急性全身性炎症反应综合征可导致多器官功能衰竭和死亡,免疫功能低下的个体易感性更高。此外,亚急性慢性炎症是多种退行性疾病(帕金森氏病,阿尔茨海默氏病和关节炎)的病理学原因。鉴于西药治疗广泛的炎症相关疾病的已知局限性以及抗生素耐药性的出现,人们对实现这些手段的补充和替代药物(CAMs)产生了新的兴趣。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号